Thrivent Financial for Lutherans Makes New Investment in National Health Investors, Inc. (NYSE:NHI)

Thrivent Financial for Lutherans acquired a new position in National Health Investors, Inc. (NYSE:NHI) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 28,858 shares of the real estate investment trust’s stock, valued at approximately $2,426,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of NHI. Sound Income Strategies LLC boosted its stake in National Health Investors by 21,963.3% in the second quarter. Sound Income Strategies LLC now owns 153,119 shares of the real estate investment trust’s stock worth $10,371,000 after purchasing an additional 152,425 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in National Health Investors in the second quarter worth $5,089,000. Easterly Investment Partners LLC acquired a new position in National Health Investors in the third quarter worth $5,632,000. Sumitomo Mitsui Trust Holdings Inc. boosted its stake in National Health Investors by 16.0% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust’s stock worth $32,034,000 after purchasing an additional 65,104 shares in the last quarter. Finally, Jupiter Asset Management Ltd. boosted its stake in National Health Investors by 61.5% in the second quarter. Jupiter Asset Management Ltd. now owns 124,153 shares of the real estate investment trust’s stock worth $8,409,000 after purchasing an additional 47,278 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Down 0.7 %

NYSE:NHI opened at $76.91 on Thursday. National Health Investors, Inc. has a 1 year low of $51.59 and a 1 year high of $86.13. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The stock has a market cap of $3.49 billion, a price-to-earnings ratio of 26.66, a PEG ratio of 5.14 and a beta of 1.05. The stock has a 50-day moving average price of $79.17 and a two-hundred day moving average price of $74.66.

National Health Investors (NYSE:NHI) last posted its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. During the same period in the previous year, the firm posted $1.08 earnings per share. The firm’s revenue was up 1.7% on a year-over-year basis. As a group, equities analysts expect that National Health Investors, Inc. will post 4.42 earnings per share for the current year.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a dividend yield of 4.68%. National Health Investors’s dividend payout ratio is currently 123.71%.

Wall Street Analyst Weigh In

NHI has been the subject of a number of recent research reports. Bank of America initiated coverage on National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price for the company. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their target price for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, Truist Financial boosted their target price on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, National Health Investors currently has a consensus rating of “Moderate Buy” and an average price target of $73.29.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.